In this recorded APAC session, Angela Macke, Zonos' Licensed Customs Broker and Trade Compliance Specialist, and Jan Hoelterling, Zonos' Head of Customs Strategy, walk through what changes for pharmaceuticals entering the U.S. postal stream on October 22, when the FDA begins receiving entry data on these shipments. This session is informational and is not legal, medical, or customs advice.
What this session covers:
The five categories of medicine that enter the U.S. mail stream: over-the-counter, prescriptions for U.S. residents, prescriptions for visitors, pet medicines, and controlled substances
What changes on October 22, when the FDA moves from spot-checking packages to receiving entry data on postal shipments
The FDA's personal importation policy, including the three-month supply guideline, the patient's statement of personal use, and prescriber details
Data to have ready for filing: FDA product code, manufacturer name and address, intended use, and the fair market value for customs
Labeling expectations, including English-language information, and how FDA import alerts can affect a shipment
What happens if the FDA holds a package, including the ten-working-day response window and how Zonos communicates with shippers
How Zonos and its sister company Evolve Trade Services handle entries for postal shipments, including the role of the foreign post
Rules for visitors, pet medicines, supplements, and why controlled substances remain prohibited, plus planning transit time around the October 22 cutover and live Q&A
Shipping pharmaceuticals into the U.S. via the postal lane (APAC session)
In this recorded APAC session, Angela Macke, Zonos' Licensed Customs Broker and Trade Compliance Specialist, and Jan Hoelterling, Zonos' Head of Customs Strategy, walk through what changes for pharmaceuticals entering the U.S. postal stream on October 22, when the FDA begins receiving entry data on these shipments. This session is informational and is not legal, medical, or customs advice.
What this session covers:
The five categories of medicine that enter the U.S. mail stream: over-the-counter, prescriptions for U.S. residents, prescriptions for visitors, pet medicines, and controlled substances
What changes on October 22, when the FDA moves from spot-checking packages to receiving entry data on postal shipments
The FDA's personal importation policy, including the three-month supply guideline, the patient's statement of personal use, and prescriber details
Data to have ready for filing: FDA product code, manufacturer name and address, intended use, and the fair market value for customs
Labeling expectations, including English-language information, and how FDA import alerts can affect a shipment
What happens if the FDA holds a package, including the ten-working-day response window and how Zonos communicates with shippers
How Zonos and its sister company Evolve Trade Services handle entries for postal shipments, including the role of the foreign post
Rules for visitors, pet medicines, supplements, and why controlled substances remain prohibited, plus planning transit time around the October 22 cutover and live Q&A